TC BioPharm (TCBP) said Friday that the Nasdaq Hearings Panel determined to delist the company's shares from the exchange for failing to comply with the minimum bid price requirement.
The company said its shares will be suspended from trading on the Nasdaq at market open March 24.
TC BioPharm said it expects its American depositary shares to be eligible to trade on the OTC Markets Monday.
Shares of the company were down over 60% in recent trading.
Price: 0.55, Change: -0.99, Percent Change: -64.09
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.